A retrospective study assessing the outcomes of patients with chronic phase chronic myeloid leukemia after discontinuation of frontline ponatinib therapy
Latest Information Update: 21 Sep 2020
At a glance
- Drugs Ponatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 21 Sep 2020 New trial record